HighVista Strategies’s NxStage Medical Inc. NXTM Stock Holding History

HighVista Strategies’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-146,903	Closed	-$4.2M	–	158
2018 Q4	$4.2M	Sell	146,903 -21,500	-13%	-$611K	3.64%	5
2018 Q3	$4.7M	Hold	168,403	–	–	2.19%	14
2018 Q2	$4.7M	Hold	168,403	–	–	2.12%	13
2018 Q1	$4.19M	Sell	168,403 -237,063	-58%	-$5.77M	1.79%	15
2017 Q4	$9.82M	Buy	+405,466	New	+$10.7M	2.74%	9

Other funds holding NXTM

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

HighVista Strategies's NXTM Position: Q1 2019 in Review

HighVista Strategies sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 146,903 shares — an estimated $4.2M sold.

HighVista Strategies first reported a position in NXTM in Q4 2017 and held it in 5 quarters. The position peaked at $9.82M in Q4 2017. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

HighVista Strategies reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
HighVista Strategies sold 146,903 NxStage Medical Inc. shares in Q1 2019, an estimated $4.2M.
HighVista Strategies first reported a position in NxStage Medical Inc. in Q4 2017 and held it in 5 quarters.
HighVista Strategies's NxStage Medical Inc. position peaked at $9.82M in Q4 2017.
1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on HighVista Strategies's 13F filing for Q1 2019, filed 15 May 2019.